Several studies have reported the spontaneous loss of hepatitis C virus (HCV) antibodies in HCVexposed persons. However, the relationship between seroreversion and spontaneous virus clearance has yet to be precisely determined in a single homogeneous population of untreated immunocompetent patients. In this study, 32 human immunodeficiency virus -seronegative hemophiliacs who had been exposed to HCV were followed for a mean duration of 141 months; 22 remained chronic carriers (68.8%). All but 1 of the nonviremic patients (90.0%) showed partial (8 cases) or complete (2 cases) seroreversion. In contrast, all but 1 of the viremic patients (95.1%) had a stable serologic profile when analyzed by a recombinant immunoblot assay. The results indicate that any HCV antibody -positive immunocompetent patient with no detectable serum HCV RNA and normal alanine aminotransferase values and whose serial samples show a progressive decrease in the level of HCV antibodies present may be considered as having a resolved infection.
Hepatitis C virus (HCV) infection is often characterized by
Patients and Methods a chronic carriage of the virus, leading to chronic hepatitis, cirrhosis, and liver cell carcinoma [1, 2] . It is frequently asPatients. One hundred seven hemophiliacs were followed as sumed that at least 50% of exposed persons remain chronically outpatients between July 1995 and December 1996 in our hemophilia treatment center. As the aim of this study was to analyze infected after primary infection [1] . Initial diagnosis of HCV serologic changes in HCV antibody levels with disease progresinfection is by detection of HCV antibody by EIA. This techsion, we retained only patients who had been followed for at least nique has been greatly improved over the last few years [3, 4] . 5 years with regular visits and for whom sequential samples were However, the presence of HCV antibody in a serum sample available for the analysis. Patients who tested positive for antibody means that the patient has been exposed to the virus but does to the human immunodeficiency virus (HIV) were excluded due to not necessarily mean that the patient harbors the virus [3] .
the potential influence of immunodeficiency on the HCV serologic Therefore, detection of HCV RNA in serum by reverse tranprofile. Forty-six patients fulfilled the criteria for inclusion in this scriptase -polymerase chain reaction (RT-PCR) in the serum analysis, 40 suffering from hemophilia A and 6 from hemophilia is the standard method for characterizing the infection outcome.
B. The mean age of patients in 1995-1996 was 33 years (range, A positive test demonstrates the presence of the virus and is .
often indicative of persistent infection, whereas a negative test Methods. HCV antibody was detected by EIA using a thirdshows clearance of the virus, indicative of recovery. Although generation assay (HCV 3.0 ELISA test system; Ortho, Raritan, highly sensitive, this approach has limitations due to the meth-NJ) and serologic profiles were analyzed using the third-generation odology itself (cutoff level of detection) and the biologic proprecombinant immunoblot assay (RIBA HCV 3.0 SIA; Chiron, Emeryville, CA). Use of RIBA made it possible to semiquantify antierties of HCV infection, such as the intermittent viremia obbodies to the core antigen and to nonstructural proteins NS3, NS4, served in some cases [5] . Therefore, additional markers are pearance of HCV antibodies may be predictive of self-limited For every patient, whether positive or negative for HCV antiinfection [6 -9] . We undertook a retrospective longitudinal body in 1995-1996, the oldest available serum sample was also study in a cohort of immunocompetent hemophiliacs with longtested to make it possible to date the seroconversion period for term follow-up to investigate this hypothesis.
those who tested positive and to detect possible serologic proof of previous infection for those who tested negative. The oldest serum sample that we tested was collected in April 1981. Changes in the serologic profile were analyzed by RIBA using at least 3 serum antibodies against NS5. All reactivities detected were strong.
Genotyping was done using the InnoLIPA HCV II assay (InnoAll 7 nonviremic patients whose antibody levels decreased had genetics, Ghent, Belgium) for patients whose sera contained HCV antibodies to core, NS3, and NS4 antigens in the earliest sam-RNA. The HCV infection was serotyped using the second-genera-
ple, and 5 also tested positive for NS5 antibody at this early antibodies.
To quantify the serologic profile, we calculated for each patient an RIBA ratio, defined as the sum of the reactivities to Results the 4 antigens (value 0 -4 for each antigen) divided by the number of reactive antigens detected with the RIBA performed Of the 46 patients, 30 (65.2%) tested positive for HCV antibody in 1995 to 1996. All had tested positive using the oldest at the last visit. This ratio was at least 3.5 for all the viremic patients (100%) but was at least 3.5 in only 2 nonviremic available serum sample, except 1, whose follow-up began in April 1985 and who seroconverted in April 1986. By studying patients (25%), showing strong association of this simple serologic analysis with the RT-PCR result. There was no difference previous sequential serum samples, we found that 2 of the 16 HCV antibody -negative hemophiliacs had previously tested in the genotype or serotype distribution of viremic and nonviremic patients. positive. Only the oldest serum sample from 1 of them, collected in 1986, contained HCV antibody. At that time, RIBA detected antibodies to both NS3 and NS4 as faint bands. SubseDiscussion quent serum samples always tested negative. For the other patient, the oldest serum sample tested strongly positive (maxiSeveral studies have reported the spontaneous loss of HCV antibodies in HCV-exposed persons [6 -9] . This has been mum intensity for antibody to core, NS3, and NS4), and then a regular decrease in antibody levels was observed until they called HCV seroreversion and can be full (complete disappearance of HCV antibody) or partial (disappearance or decreased were no longer detectable in 1996 (case 2, figure 1A) .
Of the 30 HCV antibody -positive patients, 22 (73.3%) level of antibodies to several but not all HCV antigens). It has been observed in persons coinfected with HIV [9 -12] . tested positive for HCV RNA (viremic patients). The nonviremic patients tested negative for HCV RNA for every serum However, in these cases, immunodeficiency associated with HIV infection makes interpretation of the HCV serologic data sample tested. The viremic patients tested HCV RNA -positive for every serum sample tested, except in 1 case. This particular difficult. It has been also observed in immunocompetent persons who seroreverted after complete response to interferon-a patient tested HCV RNA -positive in 3 of 4 blood samplings. The nonviremic patients never had high ALT levels (figure 2), (IFN-a) therapy [9, 13] . The impact of some of these studies was reduced by the inclusion of small numbers of cases and whereas 3 categories of viremic patients could be identified on the basis of ALT levels: those with values always below the short-term follow-up. Moreover, most used the less sensitive first-or second-generation assays. upper limit, those with values fluctuating around the upper limit, and those with consistently high values. These data supWe conducted this retrospective study to investigate the frequency and biologic characteristics of spontaneous HCV seroport the notion that nonviremic patients efficiently cleared the virus.
reversion in a homogeneous population of immunocompetent persons not treated with IFN-a, with long-term follow-up. There were striking differences between the sequential serologic profiles of viremic patients and nonviremic patients. All Therefore, we believe that this work provides informative and relevant data, contributing to our understanding of the natural but 1 patient positive for HCV RNA (95.1%) had stable serologic profiles, whereas a decrease in the level of antibodies history of HCV infection and to the better interpretation of the virologic markers associated with it. was observed in 7 (87.5%) of the 8 nonviremic patients (P õ .001). Representative cases are shown in figure 1. The mean
We found an almost complete correlation between seroreversion and resolved infection, on the basis of nonviremic status time of follow-up was similar for both categories of patients: 11.3 years for viremic and 12.5 years for nonviremic patients.
in HCV-exposed hemophiliacs. These full or partial serorever-/ 9d4c$$au49 07-01-98 22:03:35 jinfa UC: J Infect sions may be due to the loss of antigenic stimulations resulting [15] . On the basis of our data and previous reports, any HCV antibody -positive immunocompetent patient with no detectfrom elimination of the virus, whereas a stable serologic profile with a strong reactivity is probably due to continuous antigenic able serum HCV RNA and normal ALT values and whose serial samples show a progressive decrease in antibody levels stimulation associated with chronic replication of the virus. This observation has direct practical consequences for counselmay be considered to have a resolved infection. Further evaluations of a larger number of cases should demonstrate the useing. Indeed, one of the key questions when a patient is identified as HCV antibody -positive is how to distinguish between a fulness of the RIBA ratio, the sum of reactivities to the 4 antigens (value 0 -4 for each antigen) divided by the number chronic infection, with all its consequences for the future health of the patient, and more favorable self-limited infection.
of reactive antigens, in predicting self-limited infection on the basis of a single serum sample. Chronic infection is easily diagnosed on the basis of persistent viremia detected by RT-PCR and/or consistently high ALT This study also provides information on the frequency of self-limited HCV infections. Of 32 persons exposed to the values. The firm diagnosis of self-limited infection is more difficult, mainly because chronic infection can be associated virus, 30 were still HCV antibody -positive many years after infection and 2 had lost their HCV antibody. Twenty-two were with intermittent viremia (false-negative RT-PCR) and normal ALT values despite liver injury [1, 3, 5, 14] . Therefore, in HCV RNA -positive. Crude analysis suggests that chronic infection occurred in 68.8% of these patients and resolution of addition to the absence of HCV RNA by RT-PCR and normal ALT levels, surrogate markers are necessary. infection in 31.2%. However, this estimate must be treated with caution. Due to the iterative nature of their treatment, The kinetics of HCV antibody, analyzed by an immunoblot assay such as RIBA, can be used to improve reliability of hemophiliacs may have been exposed to a number of infectious batches. Therefore, the frequency of chronic carriage may be diagnosis. Other assays facilitating dissection of the antibody response to HCV could be used to provide the same information overestimated in this population compared with patients ex-
